- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT06226051
Dyrkning af små PEAPODS-undersøgelse
Growing Little PEAPODS-undersøgelse: sammenhæng mellem præmaturitet og kropssammensætning, ernæringspraksis og neuroudviklingsmæssige resultater
The goal of this clinical trial is to learn more about how the food and nutrition babies receive while in the Neonatal Intensive Care Unit (NICU) influences their ability to gain weight and fat-free mass, and their future growth and development.
Participants will:
- have body growth measurements collected using the PEAPOD device
- have nutritional information collected, and
- be followed for neurodevelopmental outcomes
Participants can expect to be in the study for 36 months.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Anslået)
Kontakter og lokationer
Studiekontakt
- Navn: Whitley Hulse, MD
- Telefonnummer: 608-620-4924
- E-mail: whulse@wisc.edu
Studiesteder
-
-
Wisconsin
-
Madison, Wisconsin, Forenede Stater, 53715
- Rekruttering
- Meriter Hospital, Inc.
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
120 neonates born inpatient at Meriter Hospital, Inc. ≤ 32 weeks 6 days (32w6d) GA (possible gestational age range from 22w0d-32w6d)
Beskrivelse
Neonate Inclusion Criteria:
- Born inpatient at Meriter Hospital, Inc. at or above 22 gestational weeks. Upper limit is 32 weeks 6 days GA (possible gestational age range from 22w0d-32w6d)
Neonate Exclusion Criteria:
-
Known genetic condition that impacts neurodevelopmental outcomes or brain structure development
-
Multiple major congenital anomalies
-
Per the investigator's opinion, the subject will likely require transfer to American Family Children's Hospital (AFCH) before 36 weeks PMA
- Any neonate who enrolls in the study and then unexpectedly requires transfer to AFCH before 36 weeks PMA will be excluded from the study if they are unable to obtain at least one body composition measurement before transfer. Body composition data points can only be collected at Meriter Hospital due to the location of PEAPOD
Birthing Parent Inclusion Criteria:
- Birthing parent must speak English or Spanish due to consent documents
- Able to understand and willing to sign a written informed consent document
- Primary caregiver of a neonate who is eligible to participate in the study
- Agrees to enroll neonate into the study
- Willing to comply with all study procedures and be available for the duration of the study
- Age 15 or older
Birthing Parent Exclusion Criteria:
- Subject is unable to provide informed consent, including subjects in foster care and subjects within state custody
- Does not plan to maintain custody of the child after birth, such as in instances of adoption or surrogacy
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: COHORT
- Tidsperspektiver: PROSPECTIVE
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
|---|---|
|
PEAPOD device
Premature babies will be evaluated using the PEAPOD Infant Body Composition measuring device |
PEAPOD is a device to that collects body composition measurements. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
To evaluate the correlation between nutritional intake over the first two weeks of life and the percent increase in fat-free mass measured by the PEAPOD
Tidsramme: Birth to 2 weeks
|
The least absolute shrinkage and selection operator technique will be utilized to determine whether fat intake predicts a percent increase in fat-free mass |
Birth to 2 weeks
|
|
To evaluate the correlation between higher nutritional intake in the first 2 weeks of life and the General Movement Assessment (GMA) and/or the Bayley Scales of Infant and Toddler Developmental Scores (Bayley)
Tidsramme: Birth to 36 months
|
The least absolute shrinkage and selection operator technique will be utilized to determine whether higher nutritional intake predicts Bayley cognitive scores |
Birth to 36 months
|
|
To evaluate the correlation between the percent increase in fat-free mass and the GMA and/or Bayley scores.
Tidsramme: Birth to 36 months
|
The least absolute shrinkage and selection operator technique will be utilized to determine whether the percent increase in fat-free mass predicts GMA scores and Bayley scores. |
Birth to 36 months
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Whitley Hulse, MD, University of Wisconsin, Madison
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Urogenitale sygdomme
- Patologiske processer
- Kvinders urogenitale sygdomme og graviditetskomplikationer
- Obstetrisk arbejde, for tidligt
- Obstetriske arbejdskomplikationer
- Graviditetskomplikationer
- Fostersygdomme
- Vækstforstyrrelser
- Medfødte, arvelige og neonatale sygdomme og abnormiteter
- Patologiske tilstande, tegn og symptomer
- For tidlig fødsel
- Fostervæksthæmning
Andre undersøgelses-id-numre
- 2026-0803
- 2023-023 (Anden identifikator: Meriter)
- A536757 (Anden identifikator: UW Madison)
- SMPH/PEDIATRICS/PEDIATRICS (Anden identifikator: UW Madison)
- Protocol Version 2/5/2026 (Anden identifikator: UW Madison)
- 2023-0931 (Anden identifikator: former IRB number)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .